Latest news
Nuvectis Pharma Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:35:23 GMTNuvectis Pharma, Inc. 2Q 2026: Net loss $(7.02)M, EPS $(0.30) — 10-Q Summary - TradingViewTradingView · Tue, 04 Aug 2026 13:11:01 GMTNVCT: Q2 2026 net loss widened to $7.0M; $106.3M raised in July extends cash runway for clinical development - TradingViewTradingView · Tue, 04 Aug 2026 13:02:33 GMTNVCT: Secured $115M financing, advanced late-stage pipeline, and reported higher R&D-driven net loss - TradingViewTradingView · Tue, 04 Aug 2026 12:29:05 GMTNVCT Q2'26 Earnings: revenue estimate is 0 USD - TradingViewTradingView · Tue, 04 Aug 2026 11:00:09 GMT